Karolin Stumpf

机构：Heidelberg University, Heidelberg Institute for Stem Cell Technology and Experimental Medicine · ORCID：0000-0002-8930-7265

发表论文 82 篇 · 总被引 110 次 · h-index 2

代表论文

Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML (2026 · Cell stem cell · 被引 4)
Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML (2026 · Repository for Publications and Research Data (ETH Zurich))
Supplementary Figure 5 from Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax (2025)
Supplementary Figure 3 from Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax (2025)
Supplementary Figure 4 from Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax (2025)
Supplementary Figure 2 from Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax (2025)